Krum, H., Schlaich, M., Sobotka, P., Scheffers, I., Kroon, A. A., & de Leeuw, P. W. (2011). Novel procedure- and device-based strategies in the management of systemic hypertension. European Heart Journal, 32(5), 537-544. https://doi.org/10.1093/eurheartj/ehq457

Thewissen, M. M. G. L., Damoiseaux, J. G. M. C., Duijvestijn, A. M., van Greevenbroek, M. M. J., van der Kallen, C. J. H., Feskens, E. J., Blaak, E. E., Schalkwijk, C. G., Stehouwer, C. D. A., Tervaert, J. W., & Ferreira, I. (2011). Abdominal Fat Mass Is Associated With Adaptive Immune Activation: The CODAM Study. Obesity, 19(8), 1690-1698. https://doi.org/10.1038/oby.2010.337

Jonk, A. M., Houben, A. J., Schaper, N. C., de Leeuw, P. W., Serne, E. H., Smulders, Y. M., & Stehouwer, C. D. A. (2011). Acute angiotensin II receptor blockade improves insulin-induced microvascular function in hypertensive individuals. Microvascular Research, 82(1), 77-83. https://doi.org/10.1016/j.mvr.2011.04.002

Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jonsson, L. S., Kolb, H., Lansink, M., Marcos, A., Margioris, A., Matusheski, N., Nordmann, H., O'Brien, J., Pugliese, G., Rizkalla, S., Schalkwijk, C. G., Tuomilehto, J., ... Winklhofer Roob, B. M. (2011). Dietary factors and low-grade inflammation in relation to overweight and obesity. British Journal of Nutrition, 106(S3), S5-S78. https://doi.org/10.1017/S0007114511005460

van Bussel, B. C. T., Schouten, F., Henry, R. M., Schalkwijk, C. G., de Boer, M. R., Ferreira, I., Smulders, Y. M., Twisk, J. W., & Stehouwer, C. D. A. (2011). Endothelial Dysfunction and Low-Grade Inflammation Are Associated With Greater Arterial Stiffness Over a 6-Year Period. Hypertension, 58(4), 588-595. https://doi.org/10.1161/HYPERTENSIONAHA.111.174557

van Bussel, B. C. T., Henry, R. M., Schalkwijk, C. G., Ferreira, I., Feskens, E. J., Streppel, M. T., Smulders, Y. M., Twisk, J. W., & Stehouwer, C. D. A. (2011). Fish consumption in healthy adults is associated with decreased circulating biomarkers of endothelial dysfunction and inflammation during a 6-year follow-up. Journal of Nutrition, 141(9), 1719-1725. https://doi.org/10.3945/jn.111.139733

Nin, J. W., Jorsal, A., Ferreira, I., Schalkwijk, C. G., Prins, M. H., Parving, H. H., Tarnow, L., Rossing, P., & Stehouwer, C. D. A. (2011). Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-year follow-up study. Diabetes Care, 34(2), 442-447. https://doi.org/10.2337/dc10-1087

Stevens, K. N., Croes, S., Boersma, R. S., Stobberingh, E. E., van der Marel, C., van der Veen, F. H., Knetsch, M. L., & Koole, L. H. (2011). Hydrophilic surface coatings with embedded biocidal silver nanoparticles and sodium heparin for central venous catheters. Biomaterials, 32(5), 1264-1269. https://doi.org/10.1016/j.biomaterials.2010.10.042

Jansen, L. J. E. S., Leffers, P., Hermans, M., Stassen, P., Masclee, A. A. M., & Keulemans, Y. (2011). Identification of patients with upper gastrointestinal bleeding who do not need immediate treatment. Netherlands Journal of Medicine, 69(9), 384-388. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=21978981

Verhagen, H., Luteijn, J., White, B., Eussen, S., Rompelberg, C., Hoekstra, J., & Tijhuis, M. J. (2011). Integrated benefit-risk assessment of food and pharma. European Journal of Pharmacology, 668(Suppl. 1). https://doi.org/10.1016/J.EJPHAR.2011.09.226

Engelen, L., Persson, F., Ferreira, I., Rossing, P., Hovind, P., Teerlink, T., Stehouwer, C. D. A., Parving, H. H., & Schalkwijk, C. G. (2011). Irbesartan treatment does not influence plasma levels of the advanced glycation end products N(epsilon)(1-carboxymethyl)lysine and N(epsilon)(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial.Nephrology Dialysis Transplantation, 26(11), 3573-3577. https://doi.org/10.1093/ndt/gfr102

Brouwers, O., Niessen, P. M., Ferreira, I., Miyata, T., Scheffer, P. G., Teerlink, T., Schrauwen, P., Brownlee, M., Stehouwer, C. D. A., & Schalkwijk, C. G. (2011). Overexpression of Glyoxalase-I Reduces Hyperglycemia-induced Levels of Advanced Glycation End Products and Oxidative Stress in Diabetic Rats.Journal of Biological Chemistry, 286(2), 1374-1380. https://doi.org/10.1074/jbc.M110.144097

Mulders, T. A., Meyer, Z., van der Donk, C. F. M., Kroon, A. A., Ferreira, I., Stehouwer, C. D. A., & Pinto-Sietsma, S. J. (2011). Patients with premature cardiovascular disease and a positive family history for cardiovascular disease are prone to recurrent events.International Journal of Cardiology, 153(1), 64-67. https://doi.org/10.1016/j.ijcard.2010.08.040

Brouwers, M. C., van Greevenbroek, M. M. J., Troutt, J., Bonner Freeman, A., Lu, A., Schaper, N. C., Konrad, R. J., & Stehouwer, C. D. A. (2011). Plasma proprotein convertase subtilisin kexin type 9 is a heritable trait of familial combined hyperlipidemia. Clinical Science, 121(9), 397-403. https://doi.org/10.1042/CS20110129

Brouwers, M. C., Troutt, J. S., van Greevenbroek, M. M. J., Ferreira, I., Feskens, E. J., van der Kallen, C. J. H., Schaper, N. C., Schalkwijk, C. G., Konrad, R. J., & Stehouwer, C. D. A. (2011). Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study. Atherosclerosis, 217(1), 263-267. https://doi.org/10.1016/j.atherosclerosis.2011.03.023

Henskens, L. H. G., van Boxtel, M. P. J., Kroon, A. A., van Oostenbrugge, R. J., Lodder, J., & de Leeuw, P. W. (2011). Sleep disturbance increases the nocturnal blood pressure level and attenuates the correlation with target organ damage. Journal of Hypertension, 29(2), 242-250. https://doi.org/10.1097/HJH.0b013e32834192d5

Jacobs, M., van Greevenbroek, M. M. J., van der Kallen, C. J. H., Ferreira, I., Blaak, E. E., Feskens, E. J., Jansen, E. H., Schalkwijk, C. G., & Stehouwer, C. D. A. (2011). The association between the metabolic syndrome and peripheral, but not coronary, artery disease is partly mediated by endothelial dysfunction: the CODAM study.European Journal of Clinical Investigation, 41(2), 167-175. https://doi.org/10.1111/j.1365-2362.2010.02392.x

Cnossen, T. T., Gladziwa, U., van de Kerkhof, J. J., Schalkwijk, C. G., Scheijen, J., van Amersfoort, J., Moret, K. E., Beerenhout, C. H., & Kooman, J. P. (2011). THE INFLUENCE OF BICARBONATE/LACTATE-BUFFERED PD FLUIDS ON N-epsilon-(CARBOXYETHYL)LYSINE AND N-epsilon-(CARBOXYMETHYL)LYSINE IN PERITONEAL EFFLUENT. Peritoneal Dialysis International, 31(2), 189-193. https://doi.org/10.3747/pdi.2010.00009

Baartmans, M. G. A., Dokter, J., Hollander, C. F., Kroon, A. A., & Oranje, A. P. (2011). Use of Skin Substitute Dressings in the Treatment of Staphylococcal Scalded Skin Syndrome in Neonates and Young Infants. Neonatology, 100(1), 9-13. https://doi.org/10.1159/000317997

Rouhl, R. P. W., van Oostenbrugge, R. J., Theunissen, R. O. M. F. I. H., Knottnerus, I. L. H., Staals, J., Henskens, L. H. G., Kroon, A. A., de Leeuw, P. W., Lodder, J., Tervaert, J. W. C., & Damoiseaux, J. G. M. C. (2010). Autoantibodies Against Oxidized Low-Density Lipoprotein in Cerebral Small Vessel Disease. Stroke, 41(11), 2687-2689. https://doi.org/10.1161/STROKEAHA.110.592725

Scheffers, I. J. M., Kroon, A. A., Schmidli, J., Jordan, J., Tordoir, J. H. M., Mohaupt, M. G., Luft, F. C., Haller, H., Menne, J., Engeli, S., Ceral, J., Eckert, S., Erglis, A., Narkiewicz, K., Philipp, T., & de Leeuw, P. W. (2010). Novel Baroreflex Activation Therapy in Resistant Hypertension Results of a European Multi-Center Feasibility Study. Journal of the American College of Cardiology, 56(15), 1254-1258. https://doi.org/10.1016/j.jacc.2010.03.089

Nur, E., Brandjes, D. P., Schnog, J.-J. B., Otten, H.-M., Fijnvandraat, K., Schalkwijk, C. G., & Biemond, B. J. (2010). Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients. British Journal of Haematology, 151(1), 62-69. https://doi.org/10.1111/j.1365-2141.2010.08320.x

Kristensen, P. L., Pedersen-Bjergaard, U., Schalkwijk, C., Olsen, N. V., & Thorsteinsson, B. (2010). Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes. European Journal of Endocrinology, 163(3), 391-398. https://doi.org/10.1530/EJE-10-0464

Croes, S., Beisser, P. S., Neef, C., Bruggeman, C. A., & Stobberingh, E. E. (2010). Unpredictable Effects of Rifampin as an Adjunctive Agent in Elimination of Rifampin-Susceptible and -Resistant Staphylococcus aureus Strains Grown in Biofilms. Antimicrobial Agents and Chemotherapy, 54(9), 3907-3912. https://doi.org/10.1128/AAC.01811-09

Jonk, A. M., Houben, A. J., Schaper, N. C., de Leeuw, P., Serne, E. H., Smulders, Y. M., & Stehouwer, C. D. (2010). Angiotensin II Enhances Insulin-Stimulated Whole-Body Glucose Disposal but Impairs Insulin-Induced Capillary Recruitment in Healthy Volunteers. Journal of Clinical Endocrinology & Metabolism, 95(8), 3901-3908. https://doi.org/10.1210/jc.2009-2587

Nin, J. W., Jorsal, A., Ferreira, I., Schalkwijk, C. G., Prins, M. H., Parving, H. H., Tarnow, L., Rossing, P., & Stehouwer, C. D. (2010). Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-yr follow-up study. Diabetes, 59(8), 2027-2032. https://doi.org/10.2337/db09-1509

Croes, S., Beisser, P. S., Terporten, P. H., Neef, C. K., Deurenberg, R. H., & Stobberingh, E. E. (2010). Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus.Clinical Microbiology and Infection, 16(7), 979-985. https://doi.org/10.1111/j.1469-0691.2009.02956.x

Rennenberg, R. J. M. W., van Varik, B. J., Schurgers, L. J., Hamulyak, K., ten Cate, H., Leiner, T., Vermeer, C., de Leeuw, P. W., & Kroon, A. A. (2010). Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood, 115(24), 5121-5123. https://doi.org/10.1182/blood-2010-01-264598

Bieghs, V., Wouters, K., van Gorp, P. J., Gijbels, M. J. J., de Winther, M. P. J., Binder, C. J., Lutjohann, D., Febbraio, M., Moore, K. J., van Bilsen, M., Hofker, M. H., & Shiri-Sverdlov, R. (2010). Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology, 138(7), 2477-2486. https://doi.org/10.1053/j.gastro.2010.02.051

Brouwers, O., Niessen, P. M., Haenen, G. R. M. M., Miyata, T., Brownlee, M., Stehouwer, C. D. A., de Mey, J. G. R., & Schalkwijk, C. G. (2010). Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress.Diabetologia, 53(5), 989-1000. https://doi.org/10.1007/s00125-010-1677-0

Hartog, J. W. L., van de Wal, R. M., Schalkwijk, C. G., Miyata, T., Jaarsma, W., Plokker, H. W. T., van Wijk, L. M., Smit, A. J., van Veldhuisen, D. J., & Voors, A. A. (2010). Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction. European journal of heart failure, 12(4), 397-403. https://doi.org/10.1093/eurjhf/hfq001

Rennenberg, R. J. M. W., de Leeuw, P. W., Kessels, A. G. H., Schurgers, L. J., Vermeer, C., van Engelshoven, J. M. A., Kemerink, G. J., & Kroon, A. A. (2010). Calcium scores and matrix Gla protein levels: association with vitamin K status. European Journal of Clinical Investigation, 40(4), 344-349. https://doi.org/10.1111/j.1365-2362.2010.02275.x

Scheffers, I. J. M., Kroon, A. A., & de Leeuw, P. W. (2010). Carotid Baroreflex Activation: Past, Present, and Future. Current Hypertension Reports, 12(2), 61-66. https://doi.org/10.1007/s11906-009-0087-5

Brouwers, M. C. G. J., van der Kallen, C. J. H., Schaper, N. C., van Greevenbroek, M. M. J., & Stehouwer, C. D. A. (2010). Five-year incidence of type 2 diabetes mellitus in patients with familial combined hyperlipidaemia. Netherlands Journal of Medicine, 68(4), 163-167. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20421657

van Onzenoort, H. A. W., Verberk, W. J., Kroon, A. A., Kessels, A. G. H., Nelemans, P. J., van der Kuy, P.-H. M., Neef, C., & de Leeuw, P. W. (2010). Effect of self-measurement of blood pressure on adherence to treatment in patients with mild-to-moderate hypertension. Journal of Hypertension, 28(3), 622-627. https://doi.org/10.1097/HJH.0b013e328334f36b

van Onzenoort, H. A. W., Verberk, W. J., Kessels, A. G. H., Kroon, A. A., Neef, C., van der Kuy, P.-H. M., & de Leeuw, P. W. (2010). Assessing Medication Adherence Simultaneously by Electronic Monitoring and Pill Count in Patients With Mild-to-Moderate Hypertension. American Journal of Hypertension, 23(2), 149-154. https://doi.org/10.1038/ajh.2009.207

Staals, J., Henskens, L. H. G., Delanghe, J. R., van Oostenbrugge, R. J., Kessels, A. G., Kroon, A. A., de Leeuw, P. W., & Lodder, J. (2010). Haptoglobin Phenotype Correlates with the Extent of Cerebral Deep White Matter Lesions in Hypertensive Patients. Current Neurovascular Research, 7(1), 1-5. https://doi.org/10.2174/156720210790820163

Engelen, L., Ferreira, I., Gaens, K. H. J., Henry, R. M. A., Dekker, J. M., Nijpels, G., Heine, R. J., 't Hart, L. M., van Greevenbroek, M. M. J., van der Kallen, C. J. H., Blaak, E. E., Feskens, E. J. M., ten Cate, H., Stehouwer, C. D. A., & Schalkwijk, C. G. (2010). The association between the-374T/A polymorphism of the receptor for advanced glycation endproducts gene and blood pressure and arterial stiffness is modified by glucose metabolism status: the Hoorn and CoDAM studies. Journal of Hypertension, 28(2), 285-293. https://doi.org/10.1097/HJH.0b013e3283330931

Wouters, K., van Bilsen, M., van Gorp, P. J., Bieghs, V., Lutjohann, D., Kerksiek, A., Staels, B., Hofker, M. H., & Sverdlov, R. (2010). Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice.Febs Letters, 584(5), 1001-1005. https://doi.org/10.1016/j.febslet.2010.01.046

Rennenberg, R. J. W. M., Schurgers, L. J., Kroon, A. A., & Stehouwer, C. D. A. (2010). Arterial calcifications. Journal of Cellular and Molecular Medicine, 14(9), 2203-2210. https://doi.org/10.1111/j.1582-4934.2010.01139.x

Brouwers, M. C., de Graaf, J., van Greevenbroek, M. M. J., Schaper, N. C., Stehouwer, C. D. A., & Stalenhoef, A. F. (2010). Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.Current Opinion in Lipidology, 21(6), 530-538. https://doi.org/10.1097/MOL.0b013e32833ea9ec

Persson, F., Rossing, P., Reinhard, H., Juhl, T., Stehouwer, C. D. A., Schalkwijk, C. G., Danser, A. H., Boomsma, F., Frandsen, E., & Parving, H. H. (2010). Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial. Diabetologia, 53(8), 1576-1580. https://doi.org/10.1007/s00125-010-1789-6

Ronden, R. A., Houben, A. J. H. M., Kessels, A. G. H., Stehouwer, C. D. A., de Leeuw, P. W., & Kroon, A. A. (2010). Predictors of clinical outcome after stent placement in atherosclerotic renal artery stenosis: a systematic review and meta-analysis of prospective studies.Journal of Hypertension, 28(12), 2370-2377. https://doi.org/10.1097/HJH.0b013e32833ec392

Eussen, S., Klungel, O., Garssen, J., Verhagen, F. J. J., van Kranen, H., van Loveren, H., & Rompelberg, C. (2010). Support of drug therapy using functional foods and dietary supplements: focus on statin therapy. British Journal of Nutrition, 103(9), 1260-1277. https://doi.org/10.1017/S0007114509993230

Hermeling, E., Hoeks, A. P. G., Winkens, M. H. M., Waltenberger, J. L., Reneman, R. S., Kroon, A. A., & Reesink, K. D. (2010). Noninvasive Assessment of Arterial Stiffness Should Discriminate Between Systolic and Diastolic Pressure Ranges. Hypertension, 55(1), 124-130. https://doi.org/10.1161/HYPERTENSIONAHA.109.143867

Plat, A. W., Kroon, A. A., Van Schayck, C. P., De Leeuw, P. W., & Stoffers, H. E. J. H. (2009). Obtaining the family history for common, multifactorial diseases by family physicians. A descriptive systematic review. European Journal of General Practice, 15(4), 231-42. https://doi.org/10.3109/13814780903447572

Plat, A. W., Stoffers, H. E., de Leeuw, P. W., van Schayck, C. P., Soomers, F. L., Kester, A. D., Aretz, K., & Kroon, A. A. (2009). The influence of six cardiovascular polymorphisms on a first event of ischemic heart disease is modified by sex and age. Coronary Artery Disease, 20(8), 499-505. https://doi.org/10.1097/MCA.0b013e328330d541

Plat, A. W., Stoffers, H. E. J. H., de Leeuw, P. W., van Schayck, C. P., Soomers, F. L., Kester, A. D. M., Aretz, K., & Kroon, A. A. (2009). Sex-specific effect of the alpha-adducin (G460W) and AGTR1 (A1166C) polymorphism on carotid intima-media thickness. Journal of Hypertension, 27(11), 2165-73. https://doi.org/10.1097/HJH.0b013e3283300506

Plat, A. W., Stoffers, H. E. J. H., Klungel, O. H., van Schayck, C. P., de Leeuw, P. W., Soomers, F. L., Schiffers, P. M., Kester, A. D. M., & Kroon, A. A. (2009). The contribution of six polymorphisms to cardiovascular risk in a Dutch high-risk primary care population: the HIPPOCRATES project. Journal of Human Hypertension, 23(10), 659-67. https://doi.org/10.1038/jhh.2009.6

Burt, D., Bruno, G., Chaturvedi, N., Schalkwijk, C., Stehouwer, C. D., Witte, D. R., Fuller, J. H., Pinach, S., Cavallo Perin, P., & Gruden, G. (2009). Anti-Heat Shock Protein 27 Antibody Levels and Diabetic Complications in the EURODIAB Study. Diabetes Care, 32(7), 1269-1271. https://doi.org/10.2337/dc08-2271